Cardinal Health Inc (CAH)

Return on equity (ROE)

Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021 Dec 31, 2020 Sep 30, 2020
Net income (ttm) US$ in thousands 1,561,000 1,558,000 1,310,000 1,263,000 852,000 552,000 639,000 156,000 261,000 463,000 -1,272,000 -1,093,000 -932,000 -954,000 555,000 1,135,000 611,000 1,151,000 1,382,000 973,000
Total stockholders’ equity US$ in thousands -2,781,000 -2,948,000 -2,991,000 -3,277,000 -3,213,000 -3,265,000 -3,449,000 -3,491,000 -2,958,000 -2,220,000 -2,213,000 -1,781,000 -709,000 -697,000 998,000 1,393,000 1,791,000 1,790,000 1,971,000 1,422,000
ROE 55.61% 81.48% 34.12% 64.30% 70.12% 68.42%

June 30, 2025 calculation

ROE = Net income (ttm) ÷ Total stockholders’ equity
= $1,561,000K ÷ $-2,781,000K
= —

The return on equity (ROE) for Cardinal Health Inc. exhibits significant fluctuations over the observed period, particularly from September 30, 2020, through September 30, 2021. During this interval, ROE experienced notable peaks, reaching as high as 81.48% in September 2021, indicating periods of high profitability relative to shareholders' equity. Conversely, there was a marked decline reaching approximately 34.12% in June 2021, followed by intermittent increases and decreases, reflecting periods of variable earnings performance and equity utilization.

After September 2021, the ROE data is not available, with all subsequent entries marked as unavailable or not reported. This absence suggests a possible lack of disclosure or changes in reporting practices, limiting the ability to assess managerial efficiency and profitability trends beyond that point.

Overall, the observed data indicates that Cardinal Health Inc. experienced volatility in its return on equity in the prior years, with periods of exceptionally high profitability aligned with robust earnings or financial strategies during 2020 and 2021. The subsequent data gaps hinder a continued analysis, thus emphasizing the importance of recent financial disclosures for a comprehensive understanding of the company’s current ROE performance.


Peer comparison

Jun 30, 2025

Company name
Symbol
ROE
Cardinal Health Inc
CAH
Cencora Inc.
COR
233.63%
McKesson Corporation
MCK